Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal allergy, eczema or food allergy.

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

Mast cell activation syndrome, or disease (MCAS), is a condition that causes mast cells to release these substances too frequently, resulting in severe allergic reactions. After detecting an ...

AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

Saskia Lambert's life completely changed at 18, when she was diagnosed with three disabilities: Mast Cell Activation Syndrome ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...